1
|
Eisen A, Lemon R. The motor deficit of ALS reflects failure to generate muscle synergies for complex motor tasks, not just muscle strength. Neurosci Lett 2021; 762:136171. [PMID: 34391870 DOI: 10.1016/j.neulet.2021.136171] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2021] [Revised: 08/09/2021] [Accepted: 08/10/2021] [Indexed: 11/17/2022]
Abstract
Customarily the motor deficits that develop in ALS are considered in terms of muscle weakness. Functional rating scales used to assess ALS in terms of functional decline do not measure the deficits when performing complex motor tasks, that make up the human skilled motor repertoire, best exemplified by tasks requiring skilled hand and finger movement. This repertoire depends primarily upon the strength of direct corticomotoneuronal (CM) connectivity from primary motor cortex to the motor units subserving skilled movements. Our review prompts the question: if accumulating evidence suggests involvement of the CM system in the early stages of ALS, what kinds of motor deficit might be expected to result, and is current methodology able to identify such deficits? We point out that the CM system is organized not in "commands" to individual muscles, but rather encodes the building blocks of complex and intricate movements, which depend upon synergy between not only the prime mover muscles, but other muscles that stabilize the limb during skilled movement. Our knowledge of the functional organization of the CM system has come both from invasive studies in non-human primates and from advanced imaging and neurophysiological techniques in humans, some of which are now being applied in ALS. CM pathology in ALS has consequences not only for muscle strength, but importantly in the failure to generate complex motor tasks, often involving elaborate muscle synergies. Our aim is to encourage innovative methodology specifically directed to assessing complex motor tasks, failure of which is likely a very early clinical deficit in ALS.
Collapse
Affiliation(s)
- Andrew Eisen
- Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada.
| | - Roger Lemon
- Department of Clinical and Motor Neurosciences, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
| |
Collapse
|
2
|
Sang Q, Wang S, Shi Y, Chen J. Flail arm syndrome patients exhibit profound abnormalities in nerve conduction: an electromyography study. Somatosens Mot Res 2019; 36:283-291. [PMID: 31777322 DOI: 10.1080/08990220.2019.1689115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Flail arm syndrome (FAS) is a rare degenerative disease of the nervous system and a variant of amyotrophic lateral sclerosis (ALS). In the current study, we sought to further delineate electromyographic changes in sensory and motor conduction of the median nerve in four FAS patients and also described one representative case of FAS in a 63-year old Chinese male patient who was admitted because of aggravating limb myasthenia for three months. Electromyography showed that FAS patients exhibited variable electromyographic changes in sensory conduction of the median nerve. Abnormal conduction velocity of the sensory nerve in bilateral median nerves was observed in one patient but normal in two other patients. Two patients had a marked reduction in median sensory nerve action potential amplitude. In addition, one patient showed significant reduction in the conduction velocity and motor nerve action potential amplitude. The latency of motor conduction of bilateral median nerves was markedly prolonged. Furthermore, the incidence rate of the F wave in the right median nerve ranged from 5% to 100%. Furthermore, all four patients exhibited abnormalities in needle electromyography in at least three regions of the four regions examined with massive denervations in large and widened motor units and diminished recruitment of motor units, indicating the simultaneous presence of both acute denervation and chronic nerve regeneration. In conclusion, this is the first detailed study of electromyographic changes in FAS and the findings help improve clinicians' understanding of this disease and differentiating the diagnoses of FAS from ALS.
Collapse
Affiliation(s)
- Qiuling Sang
- Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China
| | - Sijian Wang
- Encephalopathy Division, The Affiliated Hospital of Changchun University of TCM, Changchun, Jilin, China
| | - Yaoxun Shi
- Department of Nephrosis, Jilin Province Academy of Chinese Medical Sciences, Changchun, Jilin, China
| | - Jiajun Chen
- Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China
| |
Collapse
|
3
|
Clinical features and differential diagnosis of flail arm syndrome. J Neurol 2015; 263:390-395. [PMID: 26705123 DOI: 10.1007/s00415-015-7993-z] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Revised: 12/01/2015] [Accepted: 12/08/2015] [Indexed: 10/22/2022]
Abstract
Flail arm syndrome (FAS) is a variant of motor neuron disease which is characterized by progressive, predominantly proximal weakness and atrophy of the upper limbs (UL). Because of its heterogeneous presentation and its relatively slow progression, differential diagnosis may be difficult particularly in the early stages of the disease. The aim of this study was to investigate typical clinical features of FAS with special regard to initial symptoms and differences to classical Charcot type amyotrophic lateral sclerosis (ALS). We retrospectively evaluated the clinical features of 42 FAS patients who were seen in the outpatient clinics of 4 German centers between 2000 and 2010 and compared them to 146 sex-matched control patients with classical spinal-onset ALS. FAS patients were younger (54.7 ± 9.3 versus 59.4 ± 12.2 years), male patients were predominantly affected (3.8:1 versus 1.9:1), and FAS patients showed a prolonged survival (53 versus 33 months) compared to classical ALS patients. The share of patients with initial misdiagnoses was 54.8% and led to ineffective therapy with immunoglobulins in 26%. Initial symptoms were most frequently present either in distal muscles only or in both proximal and distal muscle groups combined (76%) and showed an asymmetric distribution pattern in the majority of cases (76%). Although all patients developed symmetric and predominantly proximal UL weakness and atrophy during the course of their disease, we found that most patients initially showed asymmetric and predominantly distal distribution of symptoms. This may contribute to difficulties in differential diagnosis and to ineffective treatment regimes.
Collapse
|
4
|
Hino S, Sasaki S. Flail arm syndrome with cytoplasmic vacuoles in remaining anterior horn motor neurons: A peculiar variant of amyotrophic lateral sclerosis. Neuropathology 2015; 35:582-6. [PMID: 26149762 DOI: 10.1111/neup.12223] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Revised: 04/30/2015] [Accepted: 04/30/2015] [Indexed: 12/12/2022]
Abstract
Flail arm (FA) syndrome, a minor subtype of amyotrophic lateral sclerosis (ALS), is characterized by progressive weakness and upper girdle wasting, but the associated pathological changes remain unclear. A 59-year-old man was admitted to our hospital with a 3-year history of upper girdle weakness. Bulbar symptom and gait disturbance gradually developed, and he was clinically diagnosed with FA syndrome. After a 10-year disease course, he died of pulmonary adenocarcinoma. Neuropathological examination revealed severe motor neuronal loss in the brain stem and anterior horn of the cervical spinal cord with bilateral pyramidal tract degeneration. The histological findings were consistent with typical ALS, including Bunina bodies and Lewy body-like and skein-like inclusions. Cytoplasmic vacuoles were found in the remaining anterior horn motor neurons of the lumbar spinal cord. This is a unique autopsy case with a long-standing clinical course that suggests that FA syndrome is an atypical form of ALS.
Collapse
Affiliation(s)
- Shuji Hino
- Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.,Department of Neurology, Saitama Red Cross Hospital, Saitama-City, Saitama, Japan
| | - Shoichi Sasaki
- Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan
| |
Collapse
|
5
|
Bogoch II, Wilson MR, Chad DA, Venna N. Acute lower motor neuron syndrome and spinal cord gray matter hyperintensities in HIV infection. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION 2015; 2:e113. [PMID: 26015990 PMCID: PMC4436596 DOI: 10.1212/nxi.0000000000000113] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/08/2014] [Accepted: 04/02/2015] [Indexed: 11/30/2022]
Abstract
Objective: To describe a novel manifestation of lower motor neuron disease in patients with well-controlled HIV infection. Methods: A retrospective study was performed to identify HIV-positive individuals with acute, painful lower motor neuron diseases. Results: Six patients were identified with HIV and lower motor neuron disease. Two patients met the inclusion criteria of well-controlled, chronic HIV infection and an acute, painful, unilateral lower motor neuron paralytic syndrome affecting the distal portion of the upper limb. These patients had segmental T2-hyperintense lesions in the central gray matter of the cervical spinal cord on MRI. One patient stabilized and the second patient improved with immunomodulatory therapy. Conclusions: This newly described syndrome expands the clinical spectrum of lower motor neuron diseases in HIV.
Collapse
Affiliation(s)
- Isaac I Bogoch
- Divisions of Internal Medicine and Infectious Diseases (I.I.B.), University Health Network, Toronto, Ontario, Canada; Department of Medicine (I.I.B.), University of Toronto, Ontario, Canada; Department of Neurology (M.R.W.), University of California, San Francisco; Department of Neurology (D.A.C., N.V.), Massachusetts General Hospital, Boston, MA; and Harvard Medical School (D.A.C., N.V.), Boston, MA
| | - Michael R Wilson
- Divisions of Internal Medicine and Infectious Diseases (I.I.B.), University Health Network, Toronto, Ontario, Canada; Department of Medicine (I.I.B.), University of Toronto, Ontario, Canada; Department of Neurology (M.R.W.), University of California, San Francisco; Department of Neurology (D.A.C., N.V.), Massachusetts General Hospital, Boston, MA; and Harvard Medical School (D.A.C., N.V.), Boston, MA
| | - David A Chad
- Divisions of Internal Medicine and Infectious Diseases (I.I.B.), University Health Network, Toronto, Ontario, Canada; Department of Medicine (I.I.B.), University of Toronto, Ontario, Canada; Department of Neurology (M.R.W.), University of California, San Francisco; Department of Neurology (D.A.C., N.V.), Massachusetts General Hospital, Boston, MA; and Harvard Medical School (D.A.C., N.V.), Boston, MA
| | - Nagagopal Venna
- Divisions of Internal Medicine and Infectious Diseases (I.I.B.), University Health Network, Toronto, Ontario, Canada; Department of Medicine (I.I.B.), University of Toronto, Ontario, Canada; Department of Neurology (M.R.W.), University of California, San Francisco; Department of Neurology (D.A.C., N.V.), Massachusetts General Hospital, Boston, MA; and Harvard Medical School (D.A.C., N.V.), Boston, MA
| |
Collapse
|
6
|
Solski JA, Yang S, Nicholson GA, Luquin N, Williams KL, Fernando R, Pamphlett R, Blair IP. A novelTARDBPinsertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis. ACTA ACUST UNITED AC 2012; 13:465-70. [DOI: 10.3109/17482968.2012.662690] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
7
|
Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 2011; 7:603-15. [PMID: 21989245 DOI: 10.1038/nrneurol.2011.150] [Citation(s) in RCA: 499] [Impact Index Per Article: 38.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Hereditary amyotrophic lateral sclerosis (ALS) encompasses a group of genetic disorders characterized by adult-onset loss of the lower and upper motor neuron systems, often with involvement of other parts of the nervous system. Cases of hereditary ALS have been attributed to mutations in 12 different genes, the most common being SOD1, FUS and TARDBP-mutations in the other genes are rare. The identified genes explain 25-35% of cases of familial ALS, but identifying the remaining genes has proved difficult. Only a few genes seem to account for significant numbers of ALS cases, with many others causing a few cases each. Hereditary ALS can be inherited in an autosomal dominant, autosomal recessive or X-linked manner, and families with low disease penetrance are frequently observed. In such families, the genetic predisposition may remain unnoticed, so many patients carry a diagnosis of isolated or sporadic ALS. The only clinical feature that distinguishes recognized hereditary from apparently sporadic ALS is a lower mean age of onset in the former. All the clinical features reported in hereditary cases (including signs of extrapyramidal, cerebellar or cognitive involvement) have also been observed in sporadic cases. Genetic counseling and risk assessment in relatives depend on establishing the specific gene defect and the disease penetrance in the particular family.
Collapse
Affiliation(s)
- Peter M Andersen
- Institute of Pharmacology and Clinical Neuroscience, Section for Neurology, Umeå University, SE-901 85 Umeå, Sweden.
| | | |
Collapse
|
8
|
McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. ACTA ACUST UNITED AC 2011; 7:557-70. [PMID: 21195356 DOI: 10.1016/j.genm.2010.11.010] [Citation(s) in RCA: 233] [Impact Index Per Article: 17.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/18/2010] [Indexed: 12/28/2022]
Abstract
BACKGROUND There is evidence that amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is more common in men than in women and that gender influences the clinical features of the disease. The causes of this are unknown. OBJECTIVE This review examines the gender differences that are found in ALS and postulates reasons for these differences. METHODS A literature review of PubMed (with no date limits) was performed to find information about gender differences in the incidence, prevalence, and clinical features of ALS, using the search terms ALS or MND and gender or sex, ALS prevalence, and SOD1 mice and gender. Articles were reviewed for information about gender differences, together with other articles that were already known to the authors. RESULTS The incidence and prevalence of ALS are greater in men than in women. This gender difference is seen in large studies that included all ALS patients (sporadic and familial), but is not seen when familial ALS is studied independently. Men predominate in the younger age groups of patients with ALS. Sporadic ALS has different clinical features in men and women, with men having a greater likelihood of onset in the spinal regions, and women tending to have onset in the bulbar region. Gender appears to have no clear effect on survival. In animals with superoxide dismutase 1 (sod1) mutations, sex does affect the clinical course of disease, with earlier onset in males. Possible reasons for the differences in ALS between men and women include different exposures to environmental toxins, different biological responses to exogenous toxins, and possibly underlying differences between the male and female nervous systems and different abilities to repair damage. CONCLUSIONS There is a complex interaction between gender and clinical phenotypes in ALS. Understanding the causes of the gender differences could give clues to processes that modify the disease.
Collapse
Affiliation(s)
- Pamela A McCombe
- The University of Queensland Centre for Clinical Research, Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia.
| | | |
Collapse
|
9
|
Cima V, Logroscino G, D'Ascenzo C, Palmieri A, Volpe M, Briani C, Pegoraro E, Angelini C, Soraru G. Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol 2009; 16:920-4. [PMID: 19473365 DOI: 10.1111/j.1468-1331.2009.02623.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND AND PURPOSE Several studies have reported an increase in ALS incidence in recent years but population-based studies in Europe do not confirm this trend. To analyze ALS incidence over time we conducted a retrospective incidence study in the Padova district of Italy (1992 to 2005). We had previously conducted a survey in the same area in the years 1980-1991. METHODS We used the archives of all the neurological wards of the Padova district to identify all subjects with a discharge diagnosis of ALS or motor neuron disease and resident in the Padova district. RESULTS We ascertained 182 patients (85 males and 97 females; male:female ratio 0.88:1) over the 14-year study period. The annual incidence rates adjusted by sex and age increased from 1.31/100,000/year in the years 1992-1994 to 1.92/100,000/year in the years 2004-2005. CONCLUSIONS This study confirmed an ALS incidence increase over the last 25 years in the Padova district. The increase in incidence may be partially explained by the ageing of the general population rather than by an improved diagnostic assessment.
Collapse
Affiliation(s)
- V Cima
- Department of Neurosciences, University of Padova, Padova, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Eisen A. Amyotrophic lateral sclerosis: A 40-year personal perspective. J Clin Neurosci 2009; 16:505-12. [PMID: 19231200 DOI: 10.1016/j.jocn.2008.07.072] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2008] [Accepted: 07/29/2008] [Indexed: 12/11/2022]
Abstract
Amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) shares with other neurodegenetrative disorders of the aging nervous system a polygenic, multifactorial aetiology. Less than 10% are familial and these too probably are associated with several interactive genes. The onset of ALS predates development of clinical symptoms by an unknown interval which may extend several years. The cause of neurodegeneration remains unknown but a common end-point is protein misfolding which in turn causes cell function failure. The complex nature of ALS has hindered therapeutic advances. In recent years longer survival is attributable largely to institution of non-invasive ventilation with BiPAP and timely implementation of percutaneous endoscopic gastrostomy (PEG) feeding. Symptomatic treatment has advanced improving quality of life. Several encouraging avenues of therapy for ALS are beginning to be emerge raising hope for real benefit. They include protective autoimmunity, vaccines against misfolded protein epitopes and other deleterious species, new drug delivery systems employing nanotechnology and the potential of stem cell therapy.
Collapse
Affiliation(s)
- Andrew Eisen
- Neurology, University of British Columbia, 2862 Highbury Street, Vancouver, British Columbia, V6R 3T6, Canada.
| |
Collapse
|
11
|
Vucic S, Kiernan MC. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis. Clin Neurophysiol 2008; 119:1088-96. [PMID: 18313980 DOI: 10.1016/j.clinph.2008.01.011] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2007] [Revised: 12/22/2007] [Accepted: 01/10/2008] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Spinobulbomuscular atrophy, or Kennedy's disease (KD), is an X-linked inherited neurodegenerative disorder that clinically may "mimic" amyotrophic lateral sclerosis (ALS). Although KD is regarded as a pure lower motor neuron disorder, recent studies have reported on the presence of corticomotoneuron dysfunction in KD, similar to ALS. To clarify these discordant findings, the present study applied novel threshold tracking transcranial magnetic stimulation (TMS) techniques to gain further insights into corticomotoneuron function and thereby possible pathophysiological processes underlying neurodegeneration in KD. METHODS Cortical excitability studies were undertaken in 7 KD patients, 55 normal controls, 45 ALS patients and 6 patients with the flail arm variant ALS (FAV), a pure lower motor neuron form of ALS. Motor evoked responses were recorded over abductor pollicis brevis. RESULTS Short-interval intracortical inhibition (SICI) in KD was similar to controls (KD 6.0+/-1.2%; controls 8.4+/-1.1%, P=0.08), but significantly greater when compared to ALS and FAV patients (ALS 0.7+/-0.7%; FAV -0.8+/-0.7%, P<0.0001). The magnetic stimulus-response curve gradient, motor evoked potential amplitude and cortical silent period duration in KD patients were similar to controls. In ALS and FAV patients, the magnetic stimulus-response curve gradient (ALS and FAV, P<0.01) and motor evoked potential amplitude (ALS and FAV, P<0.05) were significantly increased, while the cortical silent period duration was reduced (ALS, P<0.001) when compared to KD patients. CONCLUSIONS Threshold tracking TMS techniques have established normal corticomotoneuron function in KD, clearly differentiating KD from ALS. SIGNIFICANCE The present study has established normal cortical excitability in KD, inferring a lack of significant cortical involvement in this disease.
Collapse
Affiliation(s)
- Steve Vucic
- Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia
| | | |
Collapse
|
12
|
Henderson RD, Ridall PG, Hutchinson NM, Pettitt AN, McCombe PA. Bayesian statistical MUNE method. Muscle Nerve 2007; 36:206-13. [PMID: 17487869 DOI: 10.1002/mus.20805] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
We have developed a new method of motor unit number estimation (MUNE) for assessing diseases such as amyotrophic lateral sclerosis (ALS). We used data from the whole stimulus-response curve and then performed a Bayesian statistical analysis. The Bayesian method uses mathematical equations that express the basic elements of motor unit activation after electrical stimulation and allows for the sources of variability and uncertainty in this formulation. The Bayesian MUNE method was used to determine the most probable number of motor units in 8 normal subjects, 49 ALS subjects, and 3 subjects with progressive lower motor neuron (LMN) weakness. In normals the number of motor units was calculated to be 75-85 in hand and 40-58 in foot muscles. In ALS subjects the number of motor units per muscle was less than in normal subjects. In 17 ALS subjects and 3 subjects with LMN weakness the median, ulnar, or peroneal nerve was studied on repeated occasions over an average of 189 days (range 63-1,071) and the number of motor units progressively declined, with a half-life ranging from 62-834 days. The results of our MUNE technique were reproducible on replicate studies. A Bayesian statistical MUNE method is a new approach that can be used to study ALS patients serially for assessment and treatment trials.
Collapse
Affiliation(s)
- Robert D Henderson
- Department of Neurology, Royal Brisbane and Women's Hospital, Department of Medicine, University of Queensland, Butterfield Street, Herston 4029, Queensland, Australia.
| | | | | | | | | |
Collapse
|
13
|
Magistris M. Sclérose latérale amyotrophique : diagnostic différentiel et formes frontières. Rev Neurol (Paris) 2006. [DOI: 10.1016/s0035-3787(06)75167-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
14
|
Winhammar JMC, Rowe DB, Henderson RD, Kiernan MC. Assessment of disease progression in motor neuron disease. Lancet Neurol 2005; 4:229-38. [PMID: 15778102 DOI: 10.1016/s1474-4422(05)70042-9] [Citation(s) in RCA: 64] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Motor neuron disease (MND) is characterised by progressive deterioration of the corticospinal tract, brainstem, and anterior horn cells of the spinal cord. There is no pathognomonic test for the diagnosis of MND, and physicians rely on clinical criteria-upper and lower motor neuron signs-for diagnosis. The presentations, clinical phenotypes, and outcomes of MND are diverse and have not been combined into a marker of disease progression. No single algorithm combines the findings of functional assessments and rating scales, such as those that assess quality of life, with biological markers of disease activity and findings from imaging and neurophysiological assessments. Here, we critically appraise developments in each of these areas and discuss the potential of such measures to be included in the future assessment of disease progression in patients with MND.
Collapse
Affiliation(s)
- Jennica M C Winhammar
- Department of Neurology and Multidisciplinary Motor Neurone Disease Clinic, Royal North Shore Hospital, NSW, Australia
| | | | | | | |
Collapse
|